Guilin Sanjin Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Guilin Sanjin Pharmaceutical has a total shareholder equity of CN¥3.0B and total debt of CN¥470.4M, which brings its debt-to-equity ratio to 15.6%. Its total assets and total liabilities are CN¥3.9B and CN¥920.2M respectively. Guilin Sanjin Pharmaceutical's EBIT is CN¥404.8M making its interest coverage ratio -47.3. It has cash and short-term investments of CN¥1.4B.
Key information
15.6%
Debt to equity ratio
CN¥470.40m
Debt
| Interest coverage ratio | -47.3x |
| Cash | CN¥1.42b |
| Equity | CN¥3.01b |
| Total liabilities | CN¥920.16m |
| Total assets | CN¥3.93b |
Recent financial health updates
No updates
Recent updates
Investors Don't See Light At End Of Guilin Sanjin Pharmaceutical Co., Ltd.'s (SZSE:002275) Tunnel
Oct 28
Guilin Sanjin Pharmaceutical's (SZSE:002275) Anemic Earnings Might Be Worse Than You Think
Sep 04Guilin Sanjin Pharmaceutical (SZSE:002275) Is Due To Pay A Dividend Of CN¥0.30
May 23Guilin Sanjin Pharmaceutical Co., Ltd.'s (SZSE:002275) Subdued P/E Might Signal An Opportunity
May 22Does Guilin Sanjin Pharmaceutical (SZSE:002275) Deserve A Spot On Your Watchlist?
Apr 17Financial Position Analysis
Short Term Liabilities: 002275's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥595.8M).
Long Term Liabilities: 002275's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥324.3M).
Debt to Equity History and Analysis
Debt Level: 002275 has more cash than its total debt.
Reducing Debt: 002275's debt to equity ratio has increased from 4.6% to 15.6% over the past 5 years.
Debt Coverage: 002275's debt is well covered by operating cash flow (117.5%).
Interest Coverage: 002275 earns more interest than it pays, so coverage of interest payments is not a concern.